HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice.

AbstractOBJECTIVE:
Carbonyl reductase 1 (Cbr1), a recently discovered contributor to tissue glucocorticoid metabolism converting corticosterone to 20β-dihydrocorticosterone (20β-DHB), is upregulated in adipose tissue of obese humans and mice and may contribute to cardiometabolic complications of obesity. This study tested the hypothesis that Cbr1-mediated glucocorticoid metabolism influences glucocorticoid and mineralocorticoid receptor activation in adipose tissue and impacts glucose homeostasis in lean and obese states.
METHODS:
The actions of 20β-DHB on corticosteroid receptors in adipose tissue were investigated first using a combination of in silico, in vitro, and transcriptomic techniques and then in vivo administration in combination with receptor antagonists. Mice lacking one Cbr1 allele and mice overexpressing Cbr1 in their adipose tissue underwent metabolic phenotyping before and after induction of obesity with high-fat feeding.
RESULTS:
20β-DHB activated both the glucocorticoid and mineralocorticoid receptor in adipose tissue and systemic administration to wild-type mice induced glucose intolerance, an effect that was ameliorated by both glucocorticoid and mineralocorticoid receptor antagonism. Cbr1 haploinsufficient lean male mice had lower fasting glucose and improved glucose tolerance compared with littermate controls, a difference that was abolished by administration of 20β-DHB and absent in female mice with higher baseline adipose 20β-DHB concentrations than male mice. Conversely, overexpression of Cbr1 in adipose tissue resulted in worsened glucose tolerance and higher fasting glucose in lean male and female mice. However, neither Cbr1 haploinsfficiency nor adipose overexpression affected glucose dyshomeostasis induced by high-fat feeding.
CONCLUSIONS:
Carbonyl reductase 1 is a novel regulator of glucocorticoid and mineralocorticoid receptor activation in adipose tissue that influences glucose homeostasis in lean mice.
AuthorsRachel M B Bell, Elisa Villalobos, Mark Nixon, Allende Miguelez-Crespo, Lee Murphy, Angie Fawkes, Audrey Coutts, Matthew G F Sharp, Martha V Koerner, Emma Allan, Onno C Meijer, Renè Houtman, Alex Odermatt, Katharina R Beck, Scott G Denham, Patricia Lee, Natalie Z M Homer, Brian R Walker, Ruth A Morgan
JournalMolecular metabolism (Mol Metab) Vol. 48 Pg. 101225 (06 2021) ISSN: 2212-8778 [Electronic] Germany
PMID33785425 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 The Authors. Published by Elsevier GmbH.. All rights reserved.
Chemical References
  • Glucocorticoids
  • NR3C2 protein, human
  • Receptors, Glucocorticoid
  • Receptors, Mineralocorticoid
  • 20-dihydrocorticosterone
  • Alcohol Oxidoreductases
  • carbonyl reductase 1, mouse
  • Glucose
  • Corticosterone
Topics
  • Adipose Tissue (metabolism)
  • Alcohol Oxidoreductases (genetics, metabolism)
  • Animals
  • Corticosterone (analogs & derivatives, blood, pharmacology)
  • Diet, High-Fat (adverse effects)
  • Disease Models, Animal
  • Female
  • Gene Knockdown Techniques
  • Glucocorticoids (metabolism)
  • Glucose (metabolism)
  • Glucose Intolerance (genetics, metabolism)
  • HEK293 Cells
  • Homeostasis (genetics)
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Obesity (genetics, metabolism)
  • Receptors, Glucocorticoid (metabolism)
  • Receptors, Mineralocorticoid (metabolism)
  • Signal Transduction (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: